V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018498 | 260008351 | 1.74 | 92.3 | Curative (C) | 2015-05-13 | 2015-05-13 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 260025777 | RITUXIMAB |
| 260018499 | 260008354 | null | 56 | Palliative (P) | 2016-05-14 | 2016-05-27 | Rituximab (Maintenance) | N | N | 260025782 | RITUXIMAB |
| 260018500 | 260008365 | 1.68 | 80.9 | Adjuvant (A) | 2016-10-24 | 2016-10-25 | Rituximab (Maintenance) | 02 | N | 260025815 | RITUXIMAB |
| 260018501 | 260008368 | 1.85 | 102 | Disease modification (D) | 2014-07-05 | 2014-09-05 | Rituximab | 02 | N | 260025831 | RITUXIMAB |
| 260018502 | 260008370 | null | null | Disease modification (D) | null | 2016-12-29 | Rituximab (Maintenance) | 99 | N | 260025834 | RITUXIMAB |
| 260018503 | 260008378 | 1.81 | 58 | Adjuvant (A) | 2015-05-23 | 2015-12-09 | Rituximab | N | N | 260025872 | RITUXIMAB |
| 260018504 | 260008381 | null | null | Palliative (P) | 2015-10-03 | 2016-08-07 | Rituximab | N | null | 260025875 | RITUXIMAB |
| 260018505 | 260018019 | 1.62 | 95.5 | Curative (C) | 2015-02-05 | 2015-02-05 | Rituximab | Y | N | 260025893 | RITUXIMAB |
| 260018506 | 260008396 | 1.67 | 71.7 | Palliative (P) | 2015-10-17 | 2015-10-29 | Rituximab | 2 | N | 260025904 | RITUXIMAB |
| 260018507 | 260008406 | 1.7 | 77.1 | Neo-adjuvant (N) | 2017-12-22 | 2017-12-26 | Rituximab | N | N | 260025921 | RITUXIMAB |
| 260018508 | 260008411 | 1.9 | 82 | Palliative (P) | null | 2018-02-05 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260025930 | RITUXIMAB |
| 260018509 | 260008414 | null | 79.1 | Curative (C) | 2016-12-29 | 2016-12-29 | Rituximab (Maintenance) | N | null | 260025936 | RITUXIMAB |
| 260018510 | 260008423 | 0 | 58.3 | Adjuvant (A) | 2017-12-18 | 2018-02-07 | Rituximab (Maintenance) | N | N | 260025956 | RITUXIMAB |
| 260018511 | 260008431 | null | null | Disease modification (D) | 2017-08-29 | 2017-10-27 | Rituximab (Maintenance) | 02 | N | 260025968 | RITUXIMAB |
| 260018512 | 260008436 | 1.67 | 74 | Disease modification (D) | null | 2017-04-10 | Rituximab (Maintenance) | N | null | 260025977 | RITUXIMAB |
| 260018513 | 260008440 | 1.77 | 81.5 | Palliative (P) | 2017-08-08 | 2017-08-13 | Rituximab (Maintenance) | 02 | N | 260025978 | RITUXIMAB |
| 260018515 | 260008454 | null | 119.45 | Adjuvant (A) | 2016-07-04 | 2017-11-19 | Rituximab | N | Y | 260026007 | RITUXIMAB |
| 260018516 | 260008458 | 1.66 | 81 | Curative (C) | null | 2018-10-17 | Rituximab (Maintenance) | null | null | 260026023 | RITUXIMAB |
| 260018517 | 260008461 | 0 | null | Curative (C) | null | 2015-06-12 | Rituximab | 2 | N | 260026026 | RITUXIMAB |
| 260018518 | 260018027 | 1.68 | 72 | Palliative (P) | 2015-04-10 | 2015-04-11 | Rituximab (SUBCUTANEOUS Maintenance) | 99 | 2 | 260026034 | RITUXIMAB |
| 260018519 | 260014010 | 1.57 | 84.3 | Disease modification (D) | 2016-02-15 | 2016-04-14 | Rituximab | N | N | 260026041 | RITUXIMAB |
| 260018520 | 260008469 | 1.71 | null | Disease modification (D) | null | 2015-09-02 | Rituximab | N | N | 260026047 | RITUXIMAB |
| 260018521 | 260008474 | 1.8 | 86 | Curative (C) | 2013-05-25 | 2013-05-25 | Rituximab | 2 | N | 260026059 | RITUXIMAB |
| 260018522 | 260008483 | 1.7 | null | Disease modification (D) | 2017-11-11 | 2017-11-12 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | Y | 260026068 | RITUXIMAB |
| 260018523 | 260008489 | 1.9 | 54.2 | Curative (C) | 2017-05-13 | 2017-06-09 | BEP 5 Day | 2 | N | 260026077 | BEP |
| 260018524 | 260008492 | 1.53 | 102.6 | Palliative (P) | 2017-02-16 | 2017-02-27 | BEP 5 Day | null | N | 260026079 | BEP |
| 260018525 | 260018030 | 1.65 | 61 | Palliative (P) | 2017-03-24 | 2017-12-31 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260026083 | BENDAMUSTINE + RITUXIMAB |
| 260018526 | 260008503 | null | null | Curative (C) | 2018-03-13 | 2018-03-14 | BEP 5 Day | N | N | 260026089 | BEP |
| 260018527 | 260008505 | null | null | Curative (C) | 2016-12-12 | 2017-05-09 | Bendamustine+Rituximab (1st Course) | null | null | 260026090 | BENDAMUSTINE + RITUXIMAB |
| 260018528 | 260008509 | 1.89 | 73 | Disease modification (D) | 2014-03-05 | 2014-03-26 | Bendamustine+Rituximab(Sub Courses) | N | N | 260026097 | BENDAMUSTINE + RITUXIMAB |
| 260018529 | 260008513 | 1.68 | 81.64 | Unknown (U) | 2017-04-27 | 2017-06-16 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260026098 | BENDAMUSTINE + RITUXIMAB |
| 260018530 | 260008518 | 1.66 | 70.1 | Not known (9) | 2014-07-29 | 2014-08-07 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260026128 | BENDAMUSTINE + RITUXIMAB |
| 260018531 | 260014039 | 1.92 | 90.9 | Curative (C) | 2015-07-22 | 2015-07-22 | BEP 3 day | 02 | N | 260026140 | BEP |
| 260018532 | 260008529 | 1.7 | 65.4 | Curative (C) | 2016-12-19 | 2017-02-20 | BEP 5 Day | 02 | N | 260026143 | BEP |
| 260018533 | 260008533 | null | null | Palliative (P) | 2014-01-13 | 2014-02-24 | BEP 3 day | N | null | 260026144 | BEP |
| 260018534 | 260008536 | 1.71 | 76.2 | Curative (C) | 2015-12-19 | 2016-05-22 | BEP 3 day | N | N | 260026147 | BEP |
| 260018535 | 260008541 | 1.96 | 88.8 | Disease modification (D) | 2018-07-08 | 2018-07-15 | BEP 3 day | N | N | 260026151 | BEP |
| 260018536 | 260008545 | 1.59 | 55.6 | Curative (C) | 2016-11-15 | 2017-01-24 | BENDAMUSTINE + RITUXIMAB | N | N | 260026154 | BENDAMUSTINE + RITUXIMAB |
| 260018537 | 260008555 | 1.85 | 78 | Curative (C) | 2017-08-04 | 2017-08-09 | BEP 5 Day | 2 | N | 260026185 | BEP |
| 260018538 | 260008561 | 1.78 | 82.2 | Curative (C) | 2016-05-03 | 2016-05-04 | BEP 5 Day | 02 | N | 260026196 | BEP |
| 260018539 | 260008563 | 1.64 | 67.5 | Curative (C) | 2016-12-21 | 2017-04-19 | BEP 3 day | 02 | N | 260026202 | BEP |
| 260018540 | 260008566 | 1.69 | 84 | Curative (C) | 2013-06-10 | 2013-07-15 | Bendamustine+Rituximab (1st Course) | N | N | 260026214 | BENDAMUSTINE + RITUXIMAB |
| 260018541 | 260008570 | 1.7 | 88.6 | Curative (C) | 2015-04-18 | 2015-04-18 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260026218 | BENDAMUSTINE + RITUXIMAB |
| 260018542 | 260008574 | 1.56 | 69.5 | Curative (C) | 2016-09-30 | 2016-12-08 | BENDAMUSTINE + RITUXIMAB | N | null | 260026238 | BENDAMUSTINE + RITUXIMAB |
| 260018543 | 260008582 | 1.87 | 71.7 | Palliative (P) | 2018-02-07 | 2018-04-19 | Bendamustine+Rituximab(Sub Courses) | N | N | 260026244 | BENDAMUSTINE + RITUXIMAB |
| 260018544 | 260014071 | 1.86 | 55 | Disease modification (D) | 2017-01-22 | 2017-06-23 | Bendamustine+Rituximab(Sub Courses) | N | N | 260026245 | BENDAMUSTINE + RITUXIMAB |
| 260018545 | 260014072 | 1.77 | 74.5 | Not known (9) | 2016-11-23 | 2016-12-01 | BEP 3 day | N | N | 260026246 | BEP |
| 260018546 | 260008590 | 1.83 | 93.8 | null | 2017-04-21 | 2017-09-16 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 260026248 | BENDAMUSTINE + RITUXIMAB |
| 260018547 | 260008597 | 1.71 | 89.6 | Palliative (P) | 2015-07-28 | 2015-08-01 | Bendamustine+Rituximab (1st Course) | 02 | N | 260026263 | BENDAMUSTINE + RITUXIMAB |
| 260018548 | 260008601 | 1.75 | null | Palliative (P) | 2018-01-26 | 2018-02-05 | BEP 3 day | N | N | 260026270 | BEP |